The Enterprise Value as of June 2026 (TTM) for Neumora Therapeutics, Inc. Common Stock (NMRA) is 183.14M

According to Neumora Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 183.14M. This represents a change of 48.14% compared to the average of 123.63M of the last 4 quarters.

Neumora Therapeutics, Inc. Common Stock (NMRA) Historical Enterprise Value (quarterly & annually)

How has NMRA Enterprise Value performed in the past?

The mean historical Enterprise Value of Neumora Therapeutics, Inc. Common Stock over the last ten years is 1.51B. The current 183.14M Enterprise Value has changed 1.11% with respect to the historical average. Over the past ten years (40 quarters), NMRA's Enterprise Value was at its highest in in the December 2023 quarter at 2.34B. The Enterprise Value was at its lowest in in the March 2021 quarter at 0.

Neumora Therapeutics, Inc. Common Stock (NMRA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Neumora Therapeutics, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neumora Therapeutics, Inc. Common Stock (NMRA) Average Enterprise Value

How has NMRA Enterprise Value performed in the past?

The current Enterprise Value of Neumora Therapeutics, Inc. Common Stock (NMRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Neumora Therapeutics, Inc. Common Stock (NMRA) Enterprise Value vs. Peers

How is NMRA’s Enterprise Value compared to its peers?

Neumora Therapeutics, Inc. Common Stock’s Enterprise Value is less than RAPT Therapeutics, Inc. (923.92M), greater than Bicycle Therapeutics plc (-264552133.00), less than Omeros Corporation (940.92M), less than ADC Therapeutics S.A. (323.90M), less than Lexicon Pharmaceuticals, Inc. (872.47M), less than Alumis Inc. Common Stock (2.95B), greater than Fulcrum Therapeutics, Inc. (142.29M), less than 4D Molecular Therapeutics, Inc. (409.65M), greater than Prothena Corporation plc (110.11M), less than Autolus Therapeutics plc (364.21M),

Build a custom stock screener for Neumora Therapeutics, Inc. Common Stock (NMRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neumora Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neumora Therapeutics, Inc. Common Stock (NMRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neumora Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.